TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Incidences of venous thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Incidence of antifactor Xa (anti-FXa) of ≥0.2 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with PLT ≥100×10^9/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presence of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants experiencing treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Shear wave propagation velocity in kPa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatty infiltration (SSP, ISP, SSC, TM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of difficult ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of screening questionnaires suggesting a difficult ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of the screening tool to predict difficult ET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline - Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline WOMAC - Pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Episiotomy pain Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Music perception score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Music enjoyment score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood brain barrier (BBB) permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Potential efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC for daily worst bone pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of mexiletine for myotonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of mexiletine for myotonia
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in sexual life quality using Aging Men Symptom (AMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in sexual life quality through quantification of International Index of Erectile Function (IIEF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in sexual life quality through quantification of Sexual Quality of Life Questionnaire (SQoL-M)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ankle plantarflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in antibody levels against vaccine preventable pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Life as Measured by the Short Form-36 (SF-36) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional Capacity as Measured by 6-Minutes Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physiological and psychological comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants who experience at least 1 treatment-emergent adverse event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants who experience at least 1 treatment emergent AESI
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants who receive re-treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical Dementia Rating-Sum Of Boxes (CDR-SOB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Treatment Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tilt Tolerance Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination of pancreatic cancer versus non-cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Noninferiority of agreement for combined categories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (algometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sleep midpoint
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Time to first effective antibiotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Presence of decay on each tooth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of care on each tooth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastrointestinal Belly Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in symbolic number comparison task performance (reaction time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in symbolic number comparison task performance (accuracy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in brain activation during symbolic number comparison task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Food Neophobia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diet Inventory
Endpoint domain: Life impact
Endpoint subdomain: Dietary habits
Primary endpoint: Severe/serious treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: bsAUC30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patient/Care Partner Agreeing to Participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Telehealth Advance Care Planning (ACP) Completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall Response Rate (ORR) Lasting at Least 4 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total intraoperative and postoperative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in blood lactate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Predictive accuracy of a psychological screening method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty assessed with the clinical frailty scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessed with the numeric rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resilience assessed with the general self-efficacy scale, pain catastrophizing scale, and psychological inflexibility in pain scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of a daily digital diary in ICU survivors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Antioxidant Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Pain Inventory Interference Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Brief Pain Inventory Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of Shaken Baby Syndrome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: C-Peptide Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with a negative fluid balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of exclusive breastfeeding at 3 months of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measurement using Wong Baker Pain Scale (FACES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety measurement using State-Trait Anxiety Inventory for Children (STAI-CH)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knee outcome survey-Activities of daily living scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Knee osteoarthritis outcome scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Glycar-Pericardial patch related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Glycar-Pericardial patch related reintervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Anti-COVID spike protein antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recurrence-free interval (RFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Neutralizing antibody against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Markers of intestinal inflammation and microbial translocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prolonged Air Leak >5 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent completion of the prescribed aerobic exercise intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean LDL-C change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of Primary Graft Dysfunction (PDG) Grade III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective dose for 50% of patients (ED50) of morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cobb angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lordosis angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in treatment success %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer of serum neutralization titers against pseudovirus bearing Omicron subvariant XX spike protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean titer of serum neutralization titers against pseudovirus bearing SARS-CoV-2 strain XY spike protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with solicited administration site adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: General Fatigue Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Glucose changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Device or procedure-related Composite Serious Adverse Events (CSAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Gamma-Glutamyl Transferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: High-sensitivity c-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of participants flare free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm Delivery Rate
Endpoint domain: Mortality/survival
Primary endpoint: stenosis degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: percent atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: enhancement volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Global perception of intraoperative adverse event reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Global applicability of the ICARUS reporting criteria
Endpoint domain: Adverse events/effects
Primary endpoint: 90-day symptomatic venous thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: 90-day clinically relevant bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Normalization of CA19-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Versus Time Curve (AUC) of Edaravone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Plasma Concentration (Tmax) of Edaravone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Tinetti scale total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total postoperative fentanyl requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with radiological patterns associated with pulmonary complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in self-reported weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurodevelopment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients accurately diagnosed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) of BGB-26808
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in baseline flow mediated dilation (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Total Postoperative Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Annualized Event Rate of Major Clinical Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major congenital malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Nighttime dysphotopsia symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol Use-Peak Drinks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Use-drinks Per Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol Negative Consequences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Iron absorption and loss throughout pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence and nature of Dose-Limiting Toxicity (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, nature, and severity of adverse events (AEs) and immune-related AEs (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective Response Rate (ORR) according to RECIST version 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of any serious adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with viral control during an ATI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants alive and free of respiratory failure at Day 28
Endpoint domain: Mortality/survival
Primary endpoint: Change in the number of days of moderate to severe headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VO2peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuron Specific Enolase enzyme levels in blood serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concurrent validity of FuncUseRatio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laboratory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of solicited local reactions at the injection site
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with at least one adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Ultrasonic display rate of stomach and duodenal bulb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physiological parameter (visual score 1-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with adverse events of special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Root Mean Squared Deviation between Center of Mass and Center of Base of Support (RMSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe dose of oral cannabis preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Prosociality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Changes in self-reported Forgiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in self-reported Empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Perspective Taking
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Length of index hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Preparation for Decision Making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean Change from Baseline in EORTC QLQ-CIPN20 Sensory Subscale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weekly minutes of walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Differences in number of weekly minutes of walking achieved
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of cardiovascular biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of cellular phenotype of platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of clinically significant prostate cancer
Endpoint domain: Mortality/survival
Primary endpoint: Change in enuresis frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tactile sensation threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: two point discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pressure pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Drain survival time
Endpoint domain: Mortality/survival
Primary endpoint: urinary function assessed by the EPIC 50 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 2-week reduction rate of wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Concentration of Serum albumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Odds ratio of disease activity assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of agreement in classification of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive oropharyngeal dysphagia screen prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Antibody Responses to Influenza Vaccine Year One
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Antibody Responses to Influenza Vaccine Year Two
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Antibody Responses to Influenza Vaccine Year Three
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cardiorespiratory fitness assessment - Modified shuttle Walk test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation defect percentage (VDP) as detected by 129Xenon MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anterior chamber flare and cell examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in mean symptoms of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in mean symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge about Prevention of Contrast-Induced Nephrotoxicity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Correlation between ORI™ and PaO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of vaccine hesitancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status